#497
I’m no financial advisor but Eli Lilly trying to class Reta as a…
I’m no financial advisor but Eli Lilly trying to class Reta as a biologic instead of a peptide to charge more feels dumb. Reta is better than Tirz but not good enough for the average consumer to justify spending hundreds more per month on it. I don’t think they’ll be able to make it as expensive as they want to
Anonymous user report. Not medical advice. Peptides discussed are not FDA-approved for the uses described. Editorial process →
Mentioned peptides
Stay informed
New confessions and analysis, weekly.
Related Confessions
Have your own story?
Anonymous. We publish roughly 1 in 10.